Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction

Koh, Mariko Siyue; Tee, Augustine; Lasserson, Toby J; Irving, Louis

doi:10.1002/14651858.cd002739.pub3

Cited by 29 publications

(24 citation statements)

References 41 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, some elite athletes with EIA have neither a history of childhood asthma nor a family history of asthma, suggesting that environmental factors are more important than genetic inheritance [148]. The most effective therapy for EIA is regular use of ICS [122]. Early use of leukotriene inhibition may be equally effective [149,150].…”

Section: Subgroups With Treatment Implicationsmentioning

confidence: 99%

Clinically relevant subgroups in COPD and asthma

Turner

Tamási

Schleich³

et al. 2015

Eur Respir Rev

View full text Add to dashboard Cite

As knowledge of airways disease has grown, it has become apparent that neither chronic obstructive pulmonary disease (COPD) nor asthma is a simple, easily defined disease. In the past, treatment options for both diseases were limited; thus, there was less need to define subgroups. As treatment options have grown, so has our need to predict who will respond to new drugs. To date, identifying subgroups has been largely reported by detailed clinical characterisation or differences in pathobiology. These subgroups are commonly called "phenotypes"; however, the problem of defining what constitutes a phenotype, whether this should include comorbid diseases and how to handle changes over time has led to the term being used loosely.In this review, we describe subgroups of COPD and asthma patients whose clinical characteristics we believe have therapeutic or major prognostic implications specific to the lung, and whether these subgroups are constant over time. Finally, we will discuss whether the subgroups we describe are common to both asthma and COPD, and give some examples of how treatment might be tailored in patients where the subgroup is clear, but the label of asthma or COPD is not. @ERSpublications Summary of subgroups of airways disease that can be found in COPD and asthma, and their management

show abstract

Section: Subgroups With Treatment Implicationsmentioning

confidence: 99%

Clinically relevant subgroups in COPD and asthma

Turner

Tamási

Schleich³

et al. 2015

Eur Respir Rev

View full text Add to dashboard Cite

show abstract

“…61,62 However, adequate anti-inflammatory treatment may help to reduce the severity of EIB and thereby reduce the need for additional b 2 -agonist. 63 Alternative bronchodilators such as the anticholinergics (eg, ipratropium bromide) do not prevent EIB in most patients with asthma. 64 In keeping with standard guidelines, 50 it is not recommended that either long-acting b 2 -agonists or regular/frequent use of short-acting b 2 -agonists is relied on as sole therapy for athletes with asthma.…”

Section: Benefits and Dangers Of B 2 -Agonistsmentioning

confidence: 99%

Asthma and the elite athlete: Summary of the International Olympic Committee's Consensus Conference, Lausanne, Switzerland, January 22-24, 2008

Fitch

Sue‐Chu

Anderson

et al. 2008

Journal of Allergy and Clinical Immunology

190

187

View full text Add to dashboard Cite

“…The basal inflammatory state of airways in asthma may underlie their hyperreactivity to high level ventilation during exercise (19). This may explain why inhaled corticosteroids significantly attenuate EIB (20), as these medications decrease the number of epithelial eosinophils in bronchi (21).…”

Section: Prevalence Rate and Strength Of Eibmentioning

confidence: 99%

Prevalence Rate of Exercise-Induced Bronchoconstriction in Annaba (Algeria) Schoolchildren

et al. 2011

View full text Add to dashboard Cite

show abstract

Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction

Abstract: Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction (Review)

Cited by 29 publications

References 41 publications

Clinically relevant subgroups in COPD and asthma

Clinically relevant subgroups in COPD and asthma

Asthma and the elite athlete: Summary of the International Olympic Committee's Consensus Conference, Lausanne, Switzerland, January 22-24, 2008

Prevalence Rate of Exercise-Induced Bronchoconstriction in Annaba (Algeria) Schoolchildren

Contact Info

Product

Resources

About